{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:01:58Z","timestamp":1785402118645,"version":"3.56.0"},"posted":{"date-parts":[[2025,8,31]]},"group-title":"Cell Biology","reference-count":47,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T00:00:00Z","timestamp":1756598400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"award":["R01HD105714"],"award-info":[{"award-number":["R01HD105714"]}],"id":[{"id":"https:\/\/ror.org\/001d55x84","id-type":"ROR","asserted-by":"publisher"}]},{"award":["1RO1HD113717"],"award-info":[{"award-number":["1RO1HD113717"]}],"id":[{"id":"https:\/\/ror.org\/001d55x84","id-type":"ROR","asserted-by":"publisher"}]},{"award":["RO1HD094373"],"award-info":[{"award-number":["RO1HD094373"]}],"id":[{"id":"https:\/\/ror.org\/001d55x84","id-type":"ROR","asserted-by":"publisher"}]},{"award":["RO1HD076450"],"award-info":[{"award-number":["RO1HD076450"]}],"id":[{"id":"https:\/\/ror.org\/001d55x84","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,8,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  Uterine fibroids, benign tumors of the smooth muscle layer of the uterus, plague approximately 80% of the female population by age 50. While there have been efforts to understand the mechanism behind this pathophysiology, it largely remains unclear. Lack of preclinical animal models that recapitulate aberrant steroid hormone pathways in UL has significantly hampered the development of long-term hormonal therapies for uterine fibroids. In addition, cultured myometrial as well as leiomyoma smooth muscle cells rapidly silence both estrogen receptor alpha (\n                  <jats:italic>ESR1<\/jats:italic>\n                  ) and progesterone receptor (\n                  <jats:italic>PGR<\/jats:italic>\n                  ) expression through unknown mechanisms, further limiting\n                  <jats:italic>in vitro<\/jats:italic>\n                  mechanistic studies of UL. Previous work by our lab has determined the loss of REST, a master regulator of epigenetic gene silencing, in leiomyoma results in the upregulation of ESR1 targets and therefore estrogen signaling. Using ChIP-PCR, we find REST is directly associated with\n                  <jats:italic>ESR1<\/jats:italic>\n                  genomic locus, playing a role in its epigenetic regulation. ChIP-seq analysis of\n                  <jats:italic>Rest<\/jats:italic>\n                  cKO mouse uterus samples reveals a global role for REST in the regulation of progesterone receptor target genes and highlights alterations in PGR binding within the\n                  <jats:italic>Esr1<\/jats:italic>\n                  locus. Additionally, we find REST inhibition of ESR1 expression is regulated through upstream WNT planar cell polarity molecule, PRICKLE1. Based on role of REST in silencing ESR1 expression in cultured myometrial cells, our results support the development of a potential cell culture method to maintain ESR1 expression through REST modulation. Finally, we establish a broad role for REST in epigenetic regulation relevant to leiomyoma pathophysiology.\n                <\/jats:p>","DOI":"10.1101\/2025.08.29.673140","type":"posted-content","created":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T21:10:12Z","timestamp":1756674612000},"source":"Crossref","is-referenced-by-count":0,"title":["Regulatory Role for Tumor Suppressor REST on Estrogen Receptor (\n                  <i>ESR1<\/i>\n                  ) Expression and Leiomyoma Pathophysiology"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0280-0058","authenticated-orcid":false,"given":"Skylar G.","family":"Bird","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2097-135X","authenticated-orcid":false,"given":"Sumedha","family":"Gunewardena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1384-8778","authenticated-orcid":false,"given":"Ashley","family":"Cloud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5840-5818","authenticated-orcid":false,"given":"Sornakala","family":"Ganeshkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4178-146X","authenticated-orcid":false,"given":"Vargheese M.","family":"Chennathukuzhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2025090316000719000_2025.08.29.673140v1.1","unstructured":"Cardozo Er, C.A. , Banks NK , Henne MB , Stegmann BJ , Segars JH ., The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet Gynecol., 2011."},{"key":"2025090316000719000_2025.08.29.673140v1.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1209993"},{"key":"2025090316000719000_2025.08.29.673140v1.3","doi-asserted-by":"crossref","unstructured":"Gambadauro, P. , Dealing with uterine \ufb01broids in reproductive medicine. 2012. 32(3).","DOI":"10.3109\/01443615.2011.644357"},{"key":"2025090316000719000_2025.08.29.673140v1.4","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/94.4.435"},{"key":"2025090316000719000_2025.08.29.673140v1.5","doi-asserted-by":"publisher","DOI":"10.1126\/science.1112063"},{"key":"2025090316000719000_2025.08.29.673140v1.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2010.02.039"},{"issue":"4","key":"2025090316000719000_2025.08.29.673140v1.7","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/humupd\/dmac008","article-title":"Epigenomic and enhancer dysregulation in uterine leiomyomas","volume":"28","year":"2022","journal-title":"Hum Reprod Update"},{"key":"2025090316000719000_2025.08.29.673140v1.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2006.01.052"},{"key":"2025090316000719000_2025.08.29.673140v1.9","doi-asserted-by":"crossref","unstructured":"Machado-Lopez, A. , C. Simon , and A. Mas , Molecular and Cellular Insights into the Development of Uterine Fibroids. Int J Mol Sci, 2021. 22(16).","DOI":"10.3390\/ijms22168483"},{"key":"2025090316000719000_2025.08.29.673140v1.10","doi-asserted-by":"crossref","unstructured":"Islam, M.S. , et al., Selective Progesterone Receptor Modulators-Mechanisms and Therapeutic Utility. Endocr Rev, 2020. 41(5).","DOI":"10.1210\/endrev\/bnaa012"},{"key":"2025090316000719000_2025.08.29.673140v1.11","doi-asserted-by":"publisher","DOI":"10.1093\/biolre\/iox094"},{"key":"2025090316000719000_2025.08.29.673140v1.12","doi-asserted-by":"crossref","unstructured":"MacLean, J.A., 2nd and K. Hayashi , Progesterone Actions and Resistance in Gynecological Disorders. Cells, 2022. 11(4).","DOI":"10.3390\/cells11040647"},{"key":"2025090316000719000_2025.08.29.673140v1.13","doi-asserted-by":"publisher","DOI":"10.1177\/1933719116678686"},{"key":"2025090316000719000_2025.08.29.673140v1.14","doi-asserted-by":"publisher","DOI":"10.1210\/en.2008-0224"},{"key":"2025090316000719000_2025.08.29.673140v1.15","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2205524119"},{"key":"2025090316000719000_2025.08.29.673140v1.16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1215759110"},{"key":"2025090316000719000_2025.08.29.673140v1.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2012.04.052"},{"key":"2025090316000719000_2025.08.29.673140v1.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.conb.2017.12.008"},{"key":"2025090316000719000_2025.08.29.673140v1.19","doi-asserted-by":"publisher","DOI":"10.1126\/science.7871435"},{"key":"2025090316000719000_2025.08.29.673140v1.20","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90298-8"},{"key":"2025090316000719000_2025.08.29.673140v1.21","doi-asserted-by":"publisher","DOI":"10.1242\/dev.028548"},{"key":"2025090316000719000_2025.08.29.673140v1.22","doi-asserted-by":"crossref","unstructured":"Michelle M. McWilliams, F.K. , Wendy N. Jefferson , Sumedha Gunewardena , Kavya Shivashankar , Riley A. Wertenberger , Carmen J. Williams , T. Rajendra Kumar , Vargheese M. Chennathukuzhi , Estrogen receptor alpha mediated repression of PRICKLE1 destabilizes REST and promotes uterine \ufb01broid pathogenesis. bioRxiv, 2024.","DOI":"10.1101\/2024.09.09.612036"},{"key":"2025090316000719000_2025.08.29.673140v1.23","doi-asserted-by":"crossref","unstructured":"Porras, L. , H. Ismail , and S. Mader , Positive Regulation of Estrogen Receptor Alpha in Breast Tumorigenesis. Cells, 2021. 10(11).","DOI":"10.3390\/cells10112966"},{"key":"2025090316000719000_2025.08.29.673140v1.24","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-021-04174-6"},{"key":"2025090316000719000_2025.08.29.673140v1.25","doi-asserted-by":"publisher","DOI":"10.1172\/JCI81534"},{"key":"2025090316000719000_2025.08.29.673140v1.26","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209068"},{"key":"2025090316000719000_2025.08.29.673140v1.27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002494"},{"key":"2025090316000719000_2025.08.29.673140v1.28","doi-asserted-by":"publisher","DOI":"10.1038\/nrg2100"},{"key":"2025090316000719000_2025.08.29.673140v1.29","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae714"},{"key":"2025090316000719000_2025.08.29.673140v1.30","doi-asserted-by":"publisher","DOI":"10.1111\/aji.12473"},{"key":"2025090316000719000_2025.08.29.673140v1.31","doi-asserted-by":"publisher","DOI":"10.1210\/me.2011-1355"},{"key":"2025090316000719000_2025.08.29.673140v1.32","doi-asserted-by":"publisher","DOI":"10.1210\/me.7.10.1244"},{"key":"2025090316000719000_2025.08.29.673140v1.33","doi-asserted-by":"crossref","unstructured":"Carbajo-Garcia, M.C. , et al., Deciphering the Role of Histone Modi\ufb01cations in Uterine Leiomyoma: Acetylation of H3K27 Regulates the Expression of Genes Involved in Proliferation, Cell Signaling, Cell Transport, Angiogenesis and Extracellular Matrix Formation. Biomedicines, 2022. 10(6).","DOI":"10.3390\/biomedicines10061279"},{"key":"2025090316000719000_2025.08.29.673140v1.34","doi-asserted-by":"crossref","unstructured":"Yang, Q. , et al., Targeting Class I Histone Deacetylases in Human Uterine Leiomyosarcoma. Cells, 2022. 11(23).","DOI":"10.3390\/cells11233801"},{"issue":"3","key":"2025090316000719000_2025.08.29.673140v1.35","first-page":"201","article-title":"Multiple Mutations in Exon-2 of Med-12 Identi\ufb01ed in Uterine Leiomyomata","volume":"22","year":"2021","journal-title":"J Reprod Infertil"},{"key":"2025090316000719000_2025.08.29.673140v1.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2004.05.026"},{"issue":"1","key":"2025090316000719000_2025.08.29.673140v1.37","doi-asserted-by":"crossref","first-page":"e12627","DOI":"10.1002\/rmb2.12627","article-title":"Establishment of a 3D spheroid culture system to evaluate the responsiveness of uterine leiomyoma cells to female hormones","volume":"24","year":"2025","journal-title":"Reprod Med Biol"},{"issue":"1","key":"2025090316000719000_2025.08.29.673140v1.38","first-page":"36","article-title":"Growth potential of human uterine leiomyomas: some in vitro observations and their implications","volume":"66","year":"1985","journal-title":"Obstet Gynecol"},{"key":"2025090316000719000_2025.08.29.673140v1.39","doi-asserted-by":"publisher","DOI":"10.1097\/01.LAB.0000017499.51216.3E"},{"key":"2025090316000719000_2025.08.29.673140v1.40","unstructured":"Andrews, S. , FastQC: a quality control tool for high throughput sequence data. 2010."},{"issue":"1","key":"2025090316000719000_2025.08.29.673140v1.41","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14806\/ej.17.1.200","article-title":"Cutadapt removes adapter sequences from high-throughput sequencing reads","volume":"17","year":"2011","journal-title":"EMBnet.journal"},{"key":"2025090316000719000_2025.08.29.673140v1.42","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.1923"},{"key":"2025090316000719000_2025.08.29.673140v1.43","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-9-r137"},{"key":"2025090316000719000_2025.08.29.673140v1.44","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbs017"},{"key":"2025090316000719000_2025.08.29.673140v1.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2010.05.004"},{"key":"2025090316000719000_2025.08.29.673140v1.46","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku365"},{"issue":"1","key":"2025090316000719000_2025.08.29.673140v1.47","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12885-022-09280-2","article-title":"Loss of REST in breast cancer promotes tumor progression through estrogen sensitization, MMP24 and CEMIP overexpression","volume":"22","year":"2022","journal-title":"BMC Cancer"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2025.08.29.673140","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:02:01Z","timestamp":1782277321000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2025.08.29.673140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,31]]},"references-count":47,"URL":"https:\/\/doi.org\/10.1101\/2025.08.29.673140","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1016\/j.jbc.2025.111017","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2025,8,31]]},"subtype":"preprint"}}